Senescent cells are a hallmark of aging. They have also been implicated in a broad spectrum of age-related diseases and conditions including cancer, diabetes, cardiovascular disease, and Alzheimer’s ...
Synthetic biology, or "SynBio," deals with redesigning systems and objects with organic material. Analysts from Putnam Investments believe it could be the next big disruptive technology. They share ...
Sign up for the daily CJR newsletter. You know an urban neighborhood is up and coming when it gets an abbreviation like “SoMa,” for the district south of Market ...
Synthetic biology powerhouse Ginkgo Bioworks said today it will become a public company through a $17.5 billion merger with a special purpose acquisition company (SPAC) that is expected to provide up ...
Everledger CEO Leanne Kemp talks to CSIRO’s Professor Claudia Vickers to explore the vast possibilities for synbio in meeting the urgent need for the circular economy. Honeybee silk, produced via a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results